Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

At the other end of the table, the worst performers were Astellas (+11), Eli Lilly (+21) and Teva Pharma (+28). "The likes of Bayer, Gilead and Sanofi are miles ahead in their EDI scorings ...

It will also take ownership of a contract business in the US, where Endo Pharmaceuticals licenses Nebido from Bayer and sells it under the Aveed brand name. The two companies said the transaction ...

Manchester United have made an initial approach for Bayer Leverkusen striker Patrik Schick, according to reports in Germany. United are also keen on Sporting CP striker Viktor Gyokeres ...

Bayer’s BREEZE 2 has a useful on-board disc, containing 10 individual test strips. This means that it is not necessary to fumble around with loose strips and reload the meter every time to test.

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on CNSP: Disclaimer & Disclosure Report an Issue CNS Pharmaceuticals NewsMORE Related Stocks Indices Commodities Currencies ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00. The company’s shares closed yesterday at $28.68.

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

The Indian Pharmaceutical industry is ranked third in pharmaceutical production by volume, is expected to grow 9-11 percent in the financial year 2024. According to IBEF, the industry is expected ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

TEL AVIV, Israel, April 15, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing novel ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create ... March 26, 2025 Bayer acquires rights in Puhe BioPharma cancer drug candidate Bayer ...